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Introduction
The mesothelioma is a rare malignancy that has
origin from pleura (95.5%) or peritoneum (4%); mo-
re rarely it can be localized in the pericardium or in the
vaginal tunica of the testicle (1). In the USA there’s an
incidence of about 2,500 cases/year (2).
The diagnosis is often difficult both for clinical fea-
tures, due to the necessity of a differential diagnosis of
a primitive neoplasia from metastasis, and for a
morphological features, because the mesothelial mali-
gnancies can be epithelial-like (tubular-papillous, non-
glandular, solid), sarcomatous-like, undifferentiated or
mixed forms (3-4). About the 50% of the mesothelial
malignancies are epithelial-like forms, while the 25%
and the 15% are respectively mixed and sarcomatous-
like forms (5). The other cases are undifferentiated or
specific subtypes. These subtypes are represented by
desmoplastic, lymphohistiocytoid, small cells, and de-
cidual forms (3). The tubular-papillous type of the
epithelial forms have better prognosis than the sarco-
matous form (6).
Diffuse pleural and peritoneal mesotheliomas, ha-
ve many common characteristics, especially the histo-
pathology and the immunophenotype (7). The clinical
features and the treatment are different and depend on
the localization of the neoplasia. The peritoneal tu-
mour takes origin from the serosa and is characterized
by peritoneal dissemination and presence of ascites;
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when there’s invasion of the bowel, the untreatable
ascites determines the death. Usually, these neoplasias
are confined into the abdominal cavity and they rarely
invade the liver. In the advanced stages there can be
pleural invasion and metastatization (8). A study based
on the natural history of this pathology showed the
2/3 of the patients had only intrabdominal neoplasia,
and the 78% of them died for intrabdominal disease
progression (9). 
The prognosis is very poor, with a survival range
that approximately amount from 7 to 13 months (10).
Diffused malignant mesothelioma is usually treated
with palliative surgery, in order to resolve intestinal
obstruction or massive ascites, radiotherapy, che-
motherapy, but no therapy is really useful. Recently
some clinical trials demonstrated that a multimodal
therapy combining debulking surgery with peritonec-
tomy and hypertermic peritoneal perfusion increased
the survival in selected patients (10).
Currently, the asbestos is considered the more im-
portant aetiological factor of the pleural and perito-
neal mesothelioma. Between several types of asbestos,
the crocidolite (the blue asbestos) and the amosite
(the tawny asbestos) are much more powerful of chry-
sotile (the white asbestos) in causing this neoplasia.
The greater carcinogenicity of two amphibole asbe-
stos versus the asbestos of serpentine has been explai-
ned because rectilinear amphibolyc fibres easier take
lymphatic way and go into the pleural tissue than fi-
bres of serpentine which are characterized by longitu-
dinal or axial curves. In particular, the peritoneal me-
sothelioma seems to be correlated to the exposure to
the crocidolite (11). As for what is happening in Eu-
rope and in various countries as the Great Britain
(12), in Italy there’s a great increase of this disease re-
lated to a wide spread of the asbestos especially  in the
50’s and 60’s.
From 1988 to 1992 the total number of the deaths
for pleural and peritoneal mesothelioma in Italy has
been 2700 in the male population and 1519 in fema-
le (approximately 2:1) (13).
In the casuistry of the COR (Centro Operativo Re-
gionale) in Puglia (Italy) from 1980 to 1997, it has
been noticed that the sure exposures to asbestos corre-
spond to 36.8% of the cases of mesothelial malignan-
cies, the probable ones to 0.9%, the possible ones to
24.5%, the indirect ones to 5.9%; at last in 15% of the
cases there is’nt document of any exposures (14). Ac-
cording to recent studies the percentage of mesothelio-
ma in absence of exposure to asbestos is equal or infe-
rior to 1 or 2 cases/year for every million persons (15,
16).
Therefore we consider interesting our case of peri-
toneal mesothelioma in a young man for whom no ex-
posure to asbestos could be evidenced.
Case report
A 43 years old man was admitted to hospital on August 2006
with a quite subcontinuos pain, firstly localized in the right hypo-
chondrium, but recently diffuse to whole abdomen, with fever
(about 37°C), irregular alvus and abdominal meteorism. He suffe-
red from asthenia and inappetence. Moreover, he referred a loss of
weight of about 8 kg in the last 3 months. He had a medical hi-
story characterized by an appendectomy and a varicocelectomy. 
The ultrasonography  showed hepatic steatosis and a hypoe-
chogenic mass of about 4 cm of diameter under the inferior pole
of the spleen. A CT scan showed a hypo-dense, polilobated, solid
mass with a cranium-caudal extension of about 7,5 cm, adjacent to
the tail of the pancreas; no presence of lymphadenomegaly.
On admission he underwent to routinely serologic examina-
tions and to an abdominal MR. That  confirmed the data reported
in the previous CT scan. Therefore, we decided to perform a sur-
gical procedure.
Through a bilateral subcostal incision, we found a diffuse pe-
ritoneal carcinosis and a large neoplastic mass growth from the
spleen to the lower abdominal quadrants. The frozen sections
showed neoplastic cells of an adenocarcinoma. Therefore we re-
nounced radical surgery.
The patient was discharged in 6th day after a regular postope-
rative course. The definitive histological examination showed an
epithelial-like tumour with partially solid and papillary structures
and other free neoplastic elements in the ascites. The morphologic
and immunophenotypical reports were compatible with the dia-
gnosis of a peritoneal malignant mesothelioma.
Discussion
Many epidemiological studies have well docu-
mented the relationship between exposure to asbe-
stos and mesothelioma (17). Malignant mesothelio-
ma is considered a “target” neoplasia of exposure to
asbestos (18), even if, in spite of the association with
past exposure, only someone of people develops the
disease after exposure. Asbestos is considered the
most important aetiological factor for this neoplasia,
but cases of pleural mesothelioma have been obser-
ved in apparently not exposed subjects (19-20),
maybe due to the misunderstanding of the exposure,
that sometimes can pass unnoticed both to the pa-
tient than to the doctor. It is important to consider
that for the mesotelioma onset, low and very low do-
ses of asbestos too have pathogenic potentiality, as
described by Selikoff in 1978 (The triggering dose
can be small, in sure cases extraordinarily small.)
(21).
Recent medical publications assert that “all the
available informations indicate that mesothelioma,
with this characteristic of independence from the
amounting inhaled asbestos, differs not only from
the other diseases provoked from the asbestos (asbe-
stosis and pulmonary cancer) but also from all the
other tumours from cause or concomitant cause,
professional or not (chromium, from hydrocarbons,
from tobacco, etc.) for which there is a clear relation
dose/answer”.
Many scientific studies assert that in the genesis
of this tumour, some individual characteristics are
more important than others to made some subjects
much more receptive than others to the carcinogenic
action of the asbestos on the pleura and peritoneum
(22). The individual susceptibility seems to have a
primary role in the pleural genesis of malignant me-
sothelioma (23). Therefore the case we described
could be explained by this pathogenic hypothesis.
Exposing sources are present everywhere, like the in-
door and outdoor pollution, specially from brakes
and clutches of the older cars, and the building ma-
terials used until the 70’s. It is also important the in-
ner pollution of public buildings, due to the asbestos
fibre released in the building materials for its antifi-
re and insulating qualities. Such materials have been
used for the isolation especially in schools, hospitals,
theatres, cinemas, in the conditioning systems, shi-
ps. In domestic atmosphere there can be present
objects containing asbestos as old gas heater, some
domestic appliances, insulators placed behind hea-
ters in kitchen, gloves, etc. There are also the pollu-
tion of the hinterland industrial areas where is a
great use of the asbestos, the not controlled disper-
sion from rubbish dumps, natural or produced pol-
lution from industrial or mining drainages, demoli-
tions and removals of materials containing asbestos,
erosion of roofs, sheds, etc., or release from the ducts
in concrete asbestos in the drinkable water. The pol-
lution of life atmosphere, even if less than that in job
atmospheres, can represent an important problem
for the human health related to the high number of
persons who can be exposed and to the timing of the
exposure. They have been estimated in 0,2-3,7 for
100,000 the number of the deaths for pulmonary
tumour and mesothelioma due to one exposure to
0,001 asbestos fibres for millilitre (1 air/l fibre)
inhaled in scholar age beginning from 10 years old
in scholastic atmosphere for 5 years using as me-
dium age of life 75 years. Generally the atmosphere
pollution is three-fold smaller of the limit establi-
shed in job atmospheres, but even if the level ap-
pears low, however that does not mean that it can be
ignored.
We must remember that even the WHO has re-
cognized the impossibility to characterize a thre-
shold value of asbestos fibre concentration in the air
under which there isn’t any risk. There have been
alarms of the ultrafine fibre presence in the lung of
subjects only exposed to the pollution of life’s atmo-
sphere (24).
The exposure to radiations, a risk factor for pleu-
ral mesothelioma (25), is not to be considered as a
possible aetiological agent because our patient has
not had any treatment like this. For what concern
radiations, we have found in literature many cases of
mesothelioma in patients who had been subordina-
tes to radiating therapy for neoplasias, but a recent
study made by Neugut et others (26) on 250,000
patients with breast cancer and Hodgkin’ s disease,
255 of which had been subordinate to radiotherapy,
has shown a relative risk to develop mesothelioma
after thoracic radiotherapy of 1.6 with a IC to 95%
of 0.2-5.6 not statistically significant. Without ra-
diating therapy the relative risk has turned out of
0,9% (0.2-2.2). This excludes a relation between ir-
radiation of the chest and mesothelioma.
For what concern alimentary habits, other risk
factor for mesothelioma, our patient used Mediter-
ranean diet and he did not have any preferences for
foods like tomatoes, carrots, broccoli and spinach
(27). In literature the risk of development of me-
sothelioma due to a particular type of diet remains
uncertain. 
It is not possible to exclude an eventual contamina-
tion from virus SV40, that empowers the carcinogenic
action of asbestos (28). This agent would carry out its
action not by the integration in the DNA of the me-
sothelial cells, but with an episomal mechanism. Such
observations take origin from the fact that studies has
demonstrated that the intrapleural injection of SV40
is capable to induce a malignant mesothelioma in the
100% of animals from experiment independently
from the exposure to the asbestos (29).
The statistical data, available today, are contrasting
and they do not permit conclusions, probably becau-
se no study has never had a sufficiently long follow-
up to evidence malignancies characterized from long
latent periods; no case control study finished (30).
The remarkable contribution of biomolecular data
suggests the possibility of a aetiopathogenic associa-
tion between SV40 and asbestos in malignant me-
sothelioma.
In conclusion, the case we reported of a perito-
neal mesothelioma without evident exposure to
asbestos, places not few problems as regards the pos-
sible aetiological relation. In the absence of other ri-
sk factors like exposure to radiations, contamination
from SV40 and particular diet, it appears quite rea-
sonable to think that the eventual minimal exposure
to asbestos in domestic atmosphere and the conco-
mitant genetic susceptibility can be responsible of
the disease.
This case, like others described in literature (31),
make other studies necessary, in order to improve
the knowledge of the relationship between the natu-
ral and unnatural causes in development of the neo-
plasia.
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